XTX Markets’s Immunogen Inc IMGN Stock Holding History

XTX Markets’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-18,861	Closed	-$68K	–	268
2020 Q3	$68K	Buy	+18,861	New	+$76.2K	0.33%	80

Other funds holding IMGN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

XTX Markets's IMGN Position: Q4 2020 in Review

XTX Markets sold out of Immunogen Inc (IMGN) in Q4 2020, closing a stake of 18,861 shares — an estimated $68K sold.

XTX Markets first reported a position in IMGN in Q3 2020 and held it in 1 quarter. The position peaked at $68K in Q3 2020. 211 funds tracked by Wall St. Rank hold IMGN as of Q4 2020.

XTX Markets reported no remaining Immunogen Inc position as of Q4 2020 after selling out during the quarter.
XTX Markets sold 18,861 Immunogen Inc shares in Q4 2020, an estimated $68K.
XTX Markets first reported a position in Immunogen Inc in Q3 2020 and held it in 1 quarter.
XTX Markets's Immunogen Inc position peaked at $68K in Q3 2020.
211 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2020.

Based on XTX Markets's 13F filing for Q4 2020, filed 25 Jan 2021.